Indian health officials probe use of “unapproved” treatmentBMJ 2001; 322 doi: https://doi.org/10.1136/bmj.322.7295.1142/b (Published 12 May 2001) Cite this as: BMJ 2001;322:1142
- Ganapati Mudur
- New Delhi
Indian health officials are investigating the circumstances in which private doctors injected an experimental treatment agent into patients with coronary disease, although India had not approved the product for either treatment or trials.
Doctors at the Metro Hospital and Research Centre in a New Delhi suburb injected vascular endothelial growth factor into at least 16 patients with advanced coronary artery disease between early 1998 and mid-2000.
Medical teams in the United States pioneered the use of growth factors to stimulate the formation of new blood vessels in the late 1990s, and its use in India was defended by …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial